We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Convalescent Plasma Improves COVID-19 Survival Rates

By HospiMedica International staff writers
Posted on 29 Jun 2020
A new study suggests that using plasma from convalescent COVID-19 patients is safe, effective, and improves the chances of survival among those who are severely ill.

Researchers at the Mayo Clinic (Rochester, MN, USA), Michigan State University (MSU; East Lansing, USA), and other institutions conducted a study involving 20,000 patients over the age of 18 years who were confirmed with SARS-CoV-2 infection. More...
The patients were administered ABO compatible convalescent plasma donated by recently-recovered COVID-19 survivors. The treatment involved intravenous administration of 200-500 ml of convalescent plasma. Patients were assessed for improvement at four hours and seven-days after the transfusion of the plasma.

The results revealed that the incidence of all serious adverse events was low; these included transfusion reactions, thromboembolic or thrombotic events (both less than 1%), and cardiac events (3%), which were mostly judged to be unrelated to the plasma transfusion per se. Seven-day mortality was 8.6%, and was higher among more critically-ill patients, including those admitted to the intensive care unit (ICU) 10.5%), the mechanically ventilated (12.1%), and those with septic shock or multiple organ dysfunction or failure (14%). The study was published in on June 20, 2002, in Mayo Clinical Proceedings.

“It is remarkable that there was no system in place for convalescent plasma use in March 2020, and yet within months, the nation is now able to meet most of the demand, despite complex logistics,” concluded lead author Michael Joyner, MD, of the Mayo Clinic, and colleagues. “These updated data provide robust evidence that transfusion of convalescent plasma is safe in hospitalized patients with COVID-19, and support the notion that earlier administration of plasma within the clinical course of COVID-19 is more likely to reduce mortality.”

The use of convalescent plasma is an interim approach until availability of hyperimmune globulin, drug therapies, and vaccines, as the vast majority of patients who recover from COVID-19 develop some level of neutralizing antibodies to SARS-CoV-2 proteins 2-3 weeks following infection. Collecting convalescent plasma from previously infected individuals to passively-transfer antibodies in order to protect or treat human beings dates back almost 100 years, with some evidence for benefit against rabies, hepatitis B, polio, measles, influenza, Ebola and other pathogens.

Related Links:
Mayo Clinic
Michigan State University



Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Patient Monitoring System
AlarmSense
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.